Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 106

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

The P72R Polymorphism of p53 Predisposes to Obesity and Metabolic Dysfunction

Kung, Che-Pei, Leu, Julia I-Ju, Basu, Subhasree, Khaku, Sakina, Anokye-Danso, Frederick, Liu, Qin, George, Donna L., Ahima, Rexford S., Murphy, Maureen E.·2016·Cell Reports
DOI 10.1016/j.celrep.2016.02.037
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.celrep.2016.02.037

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 53

  1. Abecasis, 2012, An integrated map of genetic variation from 1,092 human genomes, Nature, 491, 56, 10.1038/nature11632 · DOI · Paper page
  2. Antohe, 2012, Diabetes mellitus risk in rheumatoid arthritis: reduced incidence with anti-tumor necrosis factor α therapy, Arthritis Care Res. (Hoboken), 64, 215, 10.1002/acr.20657 · DOI
  3. Aravinthan, 2013, Hepatocyte senescence predicts progression in non-alcohol-related fatty liver disease, J. Hepatol., 58, 549, 10.1016/j.jhep.2012.10.031 · DOI · Paper page
  4. Azzam, 2013, CSF1 is a novel p53 target gene whose protein product functions in a feed-forward manner to suppress apoptosis and enhance p53-mediated growth arrest, PLoS ONE, 8, e74297, 10.1371/journal.pone.0074297 · DOI
  5. Bechmann, 2010, Apoptosis is associated with CD36/fatty acid translocase upregulation in non-alcoholic steatohepatitis, Liver Int., 30, 850, 10.1111/j.1478-3231.2010.02248.x · DOI
  6. Beckman, 1994, Is p53 polymorphism maintained by natural selection?, Hum. Hered., 44, 266, 10.1159/000154228 · DOI · Paper page
  7. Bergamaschi, 2006, iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53, Nat. Genet., 38, 1133, 10.1038/ng1879 · DOI · Paper page
  8. Burgdorf, 2011, Studies of the association of Arg72Pro of tumor suppressor protein p53 with type 2 diabetes in a combined analysis of 55,521 Europeans, PLoS ONE, 6, e15813, 10.1371/journal.pone.0015813 · DOI
  9. Carr, 2013, Temporal effects of ethanol consumption on energy homeostasis, hepatic steatosis, and insulin sensitivity in mice, Alcohol. Clin. Exp. Res., 37, 1091, 10.1111/acer.12075 · DOI
  10. Chang, 2012, Role of p53 in neurodegenerative diseases, Neurodegener. Dis., 9, 68, 10.1159/000329999 · DOI · Paper page
  11. Chen, 2015, Gene polymorphisms in the folate metabolism and their association with MTX-related adverse events in the treatment of ALL, Tumour Biol., 36, 4913, 10.1007/s13277-015-3602-0 · doi:10.1007/s13277-015-3602-0
  12. Danilova, 2008, p53 family in development, Mech. Dev., 125, 919, 10.1016/j.mod.2008.09.003 · DOI
  13. De Iuliis, 2015, Are pharmacogenomic biomarkers an effective tool to predict taxane toxicity and outcome in breast cancer patients? Literature review, Cancer Chemother. Pharmacol., 76, 679, 10.1007/s00280-015-2818-4 · DOI
  14. Dumont, 2003, The codon 72 polymorphic variants of p53 have markedly different apoptotic potential, Nat. Genet., 33, 357, 10.1038/ng1093 · DOI · Paper page
  15. Firneisz, 2014, Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age?, World J. Gastroenterol., 20, 9072
  16. Frank, 2011, The codon 72 polymorphism of p53 regulates interaction with NF-kappaB and transactivation of genes involved in immunity and inflammation, Mol. Cell. Biol., 31, 1201, 10.1128/MCB.01136-10 · DOI
  17. Gaulton, 2008, Comprehensive association study of type 2 diabetes and related quantitative traits with 222 candidate genes, Diabetes, 57, 3136, 10.2337/db07-1731 · DOI
  18. Gloria-Bottini, 2011, Is there a role of p53 codon 72 polymorphism in the susceptibility to type 2 diabetes in overweight subjects? A study in patients with cardiovascular diseases, Diabetes Res. Clin. Pract., 91, e64, 10.1016/j.diabres.2010.11.031 · doi:10.1016/j.diabres.2010.11.031
  19. Goldstein, 2012, Regulation of lipid metabolism by p53 - fighting two villains with one sword, Trends Endocrinol. Metab., 23, 567, 10.1016/j.tem.2012.06.007 · DOI
  20. Gruben, 2014, Nonalcoholic fatty liver disease: A main driver of insulin resistance or a dangerous liaison?, Biochim. Biophys. Acta, 1842, 2329, 10.1016/j.bbadis.2014.08.004 · DOI
  21. Haukeland, 2006, Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2, J. Hepatol., 44, 1167, 10.1016/j.jhep.2006.02.011 · DOI · Paper page
  22. Kang, 2009, Single-nucleotide polymorphisms in the p53 pathway regulate fertility in humans, Proc. Natl. Acad. Sci. USA, 106, 9761, 10.1073/pnas.0904280106 · DOI · Paper page
  23. Khan, 2011, Maximum likelihood analysis of mammalian p53 indicates the presence of positively selected sites and higher tumorigenic mutations in purifying sites, Gene, 483, 29, 10.1016/j.gene.2011.05.011 · DOI
  24. Kung, 2015, Identification of TRIML2, a novel p53 target, that enhances p53 SUMOylation and regulates the transactivation of proapoptotic genes, Mol. Cancer Res., 13, 250, 10.1158/1541-7786.MCR-14-0385 · DOI
  25. Levine, 2011, The p53 family: guardians of maternal reproduction, Nat. Rev. Mol. Cell Biol., 12, 259, 10.1038/nrm3086 · DOI · Paper page
  26. Li, 2012, Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence, Cell, 149, 1269, 10.1016/j.cell.2012.04.026 · DOI · Paper page
  27. Liang, 2013, The regulation of cellular metabolism by tumor suppressor p53, Cell Biosci., 3, 9, 10.1186/2045-3701-3-9 · DOI
  28. Long, 2013, Extracellular adenosine sensing-a metabolic cell death priming mechanism downstream of p53, Mol. Cell, 50, 394, 10.1016/j.molcel.2013.03.016 · DOI
  29. Luo, 2001, Knock-in mice with a chimeric human/murine p53 gene develop normally and show wild-type p53 responses to DNA damaging agents: a new biomedical research tool, Oncogene, 20, 320, 10.1038/sj.onc.1204080 · DOI
  30. Menendez, 2013, Interactions between the tumor suppressor p53 and immune responses, Curr. Opin. Oncol., 25, 85, 10.1097/CCO.0b013e32835b6386 · DOI
  31. Minamino, 2009, A crucial role for adipose tissue p53 in the regulation of insulin resistance, Nat. Med., 15, 1082, 10.1038/nm.2014 · DOI · Paper page
  32. Molchadsky, 2013, p53 is required for brown adipogenic differentiation and has a protective role against diet-induced obesity, Cell Death Differ., 20, 774, 10.1038/cdd.2013.9 · DOI · Paper page
  33. Nomura, 2009, Inhibition of hepatic Niemann-Pick C1-like 1 improves hepatic insulin resistance, Am. J. Physiol. Endocrinol. Metab., 297, E1030, 10.1152/ajpendo.00343.2009 · DOI
  34. Ortega, 2014, Inflammation and insulin resistance exert dual effects on adipose tissue tumor protein 53 expression, Int. J. Obes., 38, 737, 10.1038/ijo.2013.163 · DOI
  35. Ota, 2013, Chemokine systems link obesity to insulin resistance, Diabetes Metab. J., 37, 165, 10.4093/dmj.2013.37.3.165 · DOI
  36. Park, 2013, Intestinal and hepatic niemann-pick c1-like 1, Diabetes Metab. J., 37, 240, 10.4093/dmj.2013.37.4.240 · DOI
  37. Park, 2014, Obesity and cancer--mechanisms underlying tumour progression and recurrence, Nat. Rev. Endocrinol., 10, 455, 10.1038/nrendo.2014.94 · DOI · Paper page
  38. Pim, 2004, p53 polymorphic variants at codon 72 exert different effects on cell cycle progression, Int. J. Cancer, 108, 196, 10.1002/ijc.11548 · DOI · Paper page
  39. Poyurovsky, 2010, P53 and aging: A fresh look at an old paradigm, Aging (Albany, N.Y.), 2, 380
  40. Puente, 2006, Comparative analysis of cancer genes in the human and chimpanzee genomes, BMC Genomics, 7, 15, 10.1186/1471-2164-7-15 · DOI
  41. Reiling, 2012, Codon 72 polymorphism (rs1042522) of TP53 is associated with changes in diastolic blood pressure over time, Eur. J. Hum. Genet., 20, 696, 10.1038/ejhg.2011.240 · DOI
  42. Reiling, 2014, Human TP53 polymorphism (rs1042522) modelled in mouse does not affect glucose metabolism and body composition, Sci. Rep., 4, 4091, 10.1038/srep04091 · doi:10.1038/srep04091
  43. Sano, 2007, p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload, Nature, 446, 444, 10.1038/nature05602 · DOI · Paper page
  44. Sellayah, 2014, On the evolutionary origins of obesity: a new hypothesis, Endocrinology, 155, 1573, 10.1210/en.2013-2103 · DOI
  45. She, 2000, Phosphoenolpyruvate carboxykinase is necessary for the integration of hepatic energy metabolism, Mol. Cell. Biol., 20, 6508, 10.1128/MCB.20.17.6508-6517.2000 · doi:10.1128/mcb.20.17.6508-6517.2000 · Paper page
  46. Shi, 2009, Winter temperature and UV are tightly linked to genetic changes in the p53 tumor suppressor pathway in Eastern Asia, Am. J. Hum. Genet., 84, 534, 10.1016/j.ajhg.2009.03.009 · DOI
  47. Speliotes, 2010, Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index, Nat. Genet., 42, 937, 10.1038/ng.686 · DOI · Paper page
  48. Sucheston, 2011, Natural selection and functional genetic variation in the p53 pathway, Hum. Mol. Genet., 20, 1502, 10.1093/hmg/ddr028 · DOI
  49. Thomas, 1999, Two polymorphic variants of wild-type p53 differ biochemically and biologically, Mol. Cell. Biol., 19, 1092, 10.1128/MCB.19.2.1092 · DOI · Paper page
  50. Tomita, 2012, p53/p66Shc-mediated signaling contributes to the progression of non-alcoholic steatohepatitis in humans and mice, J. Hepatol., 57, 837, 10.1016/j.jhep.2012.05.013 · DOI · Paper page
  51. Wang, 2005, Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men, Am. J. Clin. Nutr., 81, 555, 10.1093/ajcn/81.3.555 · DOI · Paper page
  52. Whibley, 2009, p53 polymorphisms: cancer implications, Nat. Rev. Cancer, 9, 95, 10.1038/nrc2584 · DOI · Paper page
  53. Zhang, 2014, Tumor suppressor p53 cooperates with SIRT6 to regulate gluconeogenesis by promoting FoxO1 nuclear exclusion, Proc. Natl. Acad. Sci. USA, 111, 10684, 10.1073/pnas.1411026111 · DOI · Paper page

Cited by

See all 106

Metadata

Authors
Kung, C.-P., Leu, J. I.-J., Basu, S., Khaku, S., Anokye-Danso, F., Liu, Q., George, D. L., Ahima, R. S., & Murphy, M. E.
Venue
Cell Reports
Publisher
Elsevier BV
Published
2016-03
Volume
14
Issue
10
Pages
2413-2425
ISSN
2211-1247
DOI
10.1016/j.celrep.2016.02.037
Cited by
106
References
6
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The P72R Polymorphism of p53 Predisposes to Obesity and Metabolic Dysfunction. https://app.cochat.ai/papers/10.1016/j.celrep.2016.02.037
The paper
Kung, C.-P., Leu, J. I.-J., Basu, S., Khaku, S., Anokye-Danso, F., Liu, Q., George, D. L., Ahima, R. S., & Murphy, M. E. (2016). The P72R Polymorphism of p53 Predisposes to Obesity and Metabolic Dysfunction. Cell Reports. https://doi.org/10.1016/j.celrep.2016.02.037

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.